Alexander Lyon, EHRA 2019 – Cardio-oncology, a new Frontier for Arrhythmia Specialists
We were excited to catch Dr Alexander Lyon (Senior Lecturer and Consultant Cardiologist, Royal Brompton Hospital, London, UK) at EHRA 2019, to celebrate the introduction of the new ESC Council of Cardio-oncology. Cardio-oncology is a new and important subspecialty and Dr Lyon discusses the key responsibilities and challenges of a cardiologist in the management of a patient with cancer
Filmed at EHRA 2019, Lisbon.
Speaker’s Disclosures: Dr Alexander Lyon has received speaker, advisory board or consultancy fees and/or research grants from Pfizer, Novartis, Servier, Amgen, Clinigen Group, Takeda, Roche, Eli Lily, Eisai, Bristol Myers Squibb, Ferring Pharmaceuticals and Boehringer Ingelheim.
Questions:
- Cardiologists are increasingly involved in the management of patients with cancer – what are the key challenges faced in providing multidisciplinary support to these patients? (0:14)
- How do cardiac implantable electronic devices complicate cancer care? (0:14)
- Which other cardiovascular conditions complicate cancer treatment, and how? (2:10)
- How can cardio-oncology services develop to improve the support of patients in the future? (3:31)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
